Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cryolife Inc (CRY)  
$31.19 0.57 (1.86%) as of 4:30 Fri 6/27


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 42,700,000
Market Cap: 1.33(B)
Last Volume: 543,052 Avg Vol: 240,157
52 Week Range: $22.19 - $31.7
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Specialized Health Services

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P SMALLCAP 600

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 6.1
Insider 3/6 Months : 6.7
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Artivion is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. Co. has the following product families: aortic stents and stent grafts, surgical sealants, On-X® mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stents and stent grafts include JOTEC® stent grafts and surgical products, the Ascyrus Medical Dissection Stent hybrid prosthesis, and the NEXUS® endovascular stent graft system. Surgical sealants include BioGlue® Surgical Adhesive products.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 2,100 2,100 2,100
Total Buy Value $0 $53,141 $53,141 $53,141
Total People Bought 0 1 1 1
Total Buy Transactions 0 2 2 2
Total Shares Sold 75,554 275,104 336,655 650,082
Total Sell Value $2,182,496 $7,253,298 $8,933,863 $14,989,121
Total People Sold 3 7 9 11
Total Sell Transactions 7 22 31 98
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 883
  Page 1 of 36  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Stanton Marshall S. SVP, Clinical & MD Affair   •       –      –    2025-06-17 4 AS $29.50 $442,500 D/D (15,000) 64,200 5%     
   Stanton Marshall S. SVP, Clinical & MD Affair   •       –      –    2025-06-13 4 AS $28.42 $743,131 D/D (26,132) 79,200 10%     
   Holloway Jean F SVP, General Counsel   •       –      –    2025-05-27 4 S $29.00 $253,692 D/D (8,748) 178,510 -7%     
   Semedo Anthony B. Director   –       •      –    2025-05-23 4/A S $28.47 $74,027 D/D (2,600) 39,384     -
   Semedo Anthony B. Director   –       •      –    2025-05-23 4 S $28.47 $74,027 D/D (2,600) 33,059 -9%     
   Burbank Jeffrey H Director   –       •      –    2025-05-22 4 A $0.00 $0 D/D 6,325 53,796     -
   Bullock James W Director   –       •      –    2025-05-22 4 A $0.00 $0 D/D 6,325 68,647     -
   Hoff Elizabeth A Director   –       •      –    2025-05-22 4 A $0.00 $0 D/D 6,325 31,389     -
   Borgstrom Marna P Director   –       •      –    2025-05-22 4 A $0.00 $0 D/D 6,325 49,088     -
   Bevevino Daniel J Director   –       •      –    2025-05-22 4 A $0.00 $0 D/D 6,325 150,061     -
   Salveson Jon W Director   –       •      –    2025-05-22 4 A $0.00 $0 D/D 6,325 129,840     -
   Ackerman Thomas F Director   –       •      –    2025-05-22 4 A $0.00 $0 D/D 6,325 149,896     -
   Semedo Anthony B. Director   –       •      –    2025-05-22 4 A $0.00 $0 D/D 6,325 41,984     -
   Holloway Jean F SVP, General Counsel   •       –      –    2025-05-21 4 S $29.00 $287,854 D/D (9,926) 187,258 -9%     
   Stanton Marshall S. SVP, Clinical & MD Affair   •       –      –    2025-05-09 4 S $29.13 $307,265 D/D (10,548) 105,332 -8%     
   Holloway Jean F SVP, General Counsel   •       –      –    2025-03-11 4 AS $23.61 $425,510 D/D (18,020) 197,184 33%     
   Holloway Jean F SVP, General Counsel   •       –      –    2025-03-11 4 OE $21.55 $411,433 D/D 19,092 215,204     -
   Davis John E Chief Commercial Officer   •       –      –    2025-03-11 4 AS $23.61 $356,549 D/D (15,100) 208,778 33%     
   Davis John E Chief Commercial Officer   •       –      –    2025-03-11 4 OE $21.55 $342,861 D/D 15,910 223,878     -
   Stanton Marshall S. SVP, Clinical & MD Affair   •       –      –    2025-03-06 4 S $24.80 $39,761 D/D (1,603) 115,880 -26%     
   Stanton Marshall S. SVP, Clinical & MD Affair   •       –      –    2025-03-06 4 A $0.00 $0 D/D 19,240 117,483     -
   Horton Amy VP, Chief Accounting Officer   •       –      –    2025-03-06 4 S $24.80 $25,995 D/D (1,048) 146,651 -26%     
   Horton Amy VP, Chief Accounting Officer   •       –      –    2025-03-06 4 A $0.00 $0 D/D 10,261 147,699     -
   Davis John E Chief Commercial Officer   •       –      –    2025-03-06 4 S $24.80 $64,939 D/D (2,618) 207,968 -26%     
   Davis John E Chief Commercial Officer   •       –      –    2025-03-06 4 A $0.00 $0 D/D 25,654 210,586     -
  883 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 36
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us